BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38629365)

  • 1. Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway.
    Zhang J; Yang H; Wen F; Li Q; Luo H; Zi D
    Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38629365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells.
    Wen F; Wu ZY; Nie L; Zhang QZ; Qin YK; Zhou ZL; Wu JJ; Zhao X; Tan J; Sawmiller D; Zi D
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31316002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.
    Ding X; Hou L; Zhang H; Chen Z; Liu Z; Gong J; Tang Z; Hu R
    Dis Markers; 2022; 2022():9464094. PubMed ID: 36157221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
    Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
    Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma.
    Fan M; Wang K; Wei X; Yao H; Chen Z; He X
    Int J Oncol; 2019 Dec; 55(6):1385-1395. PubMed ID: 31638200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells.
    Hao J; Liang C; Jiao B
    Oncol Lett; 2015 Jun; 9(6):2525-2533. PubMed ID: 26137101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Xu YP; Dong ZN; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Huang XY; Guo CY
    Dig Dis Sci; 2022 Feb; 67(2):559-568. PubMed ID: 33576946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.
    Hao J; Wang Z; Wang Y; Liang Z; Zhang X; Zhao Z; Jiao B
    Oncol Rep; 2015 Jun; 33(6):2954-62. PubMed ID: 25823503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
    Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
    Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown EIF3C Suppresses Cell Proliferation and Increases Apoptosis in Pancreatic Cancer Cell.
    Jiao H; Zeng L; Yang S; Zhang J; Lou W
    Dose Response; 2020; 18(3):1559325820950061. PubMed ID: 32973416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles.
    Liu H; Huang Y; Li Z; Han S; Liu T; Zhao Q
    Front Immunol; 2023; 14():1343428. PubMed ID: 38274829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.
    Ding L; Wang R; Zheng Q; Shen D; Wang H; Lu Z; Luo W; Xie H; Ren L; Jiang M; Yu C; Zhou Z; Lin Y; Lu H; Xue D; Su W; Xia L; Neuhaus J; Cheng S; Li G
    J Exp Clin Cancer Res; 2022 Jun; 41(1):187. PubMed ID: 35650605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer.
    Shintani T; Higashisaka K; Maeda M; Hamada M; Tsuji R; Kurihara K; Kashiwagi Y; Sato A; Obana M; Yamamoto A; Kawasaki K; Lin Y; Kijima T; Kinehara Y; Miwa Y; Maeda S; Morii E; Kumanogoh A; Tsutsumi Y; Nagatomo I; Fujio Y
    Oncotarget; 2018 Dec; 9(101):37520-37533. PubMed ID: 30680067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis.
    Hu C; Wang Y; Li A; Zhang J; Xue F; Zhu L
    J Cell Physiol; 2019 Jun; 234(6):9225-9232. PubMed ID: 30362562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNK.
    Gao W; Hu Y; Zhang Z; Du G; Yin L; Yin Z
    Onco Targets Ther; 2019; 12():1225-1235. PubMed ID: 30863090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells.
    Song N; Wang Y; Gu XD; Chen ZY; Shi LB
    J Zhejiang Univ Sci B; 2013 Jun; 14(6):451-9. PubMed ID: 23733421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of
    Hu J; Luo H; Xu Y; Luo G; Xu S; Zhu J; Song D; Sun Z; Kuang Y
    Cancer Invest; 2019; 37(4-5):199-208. PubMed ID: 31181967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eIF3c: a potential therapeutic target for cancer.
    Emmanuel R; Weinstein S; Landesman-Milo D; Peer D
    Cancer Lett; 2013 Aug; 336(1):158-66. PubMed ID: 23623922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
    Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
    Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.